Page last updated: 2024-08-23

daunorubicin and Hyperglycemia

daunorubicin has been researched along with Hyperglycemia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haymond, MW; Margolin, JF; McKay, SV; Okcu, MF; Sonabend, RY; Yan, J1
George, S; Haggard, ME; Humphrey, GB; Lowman, JT; Starling, KA; Sutow, WW; Vietti, TJ1
Aur, RJ; Pratt, CB; Simone, JV1
Blom, J; Burningham, R; Cuttner, J; Falkson, G; Glidewell, O; Holland, JF; Levy, RN; Moon, JH; Onuma, T; Rosner, F; Silver, RT1

Other Studies

4 other study(ies) available for daunorubicin and Hyperglycemia

ArticleYear
Hyperglycemia during induction therapy is associated with poorer survival in children with acute lymphocytic leukemia.
    The Journal of pediatrics, 2009, Volume: 155, Issue:1

    Topics: Antineoplastic Agents; Asparaginase; Blood Glucose; Child; Child, Preschool; Daunorubicin; Dexamethasone; Escherichia coli; Female; Glucocorticoids; Humans; Hyperglycemia; Male; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Severity of Illness Index; Vincristine

2009
Evaluation of dose and schedule of L-asparaginase in multidrug therapy of childhood leukemia.
    Medical and pediatric oncology, 1976, Volume: 2, Issue:4

    Topics: Acute Disease; Adolescent; Asparaginase; Child; Child, Preschool; Daunorubicin; Drug Evaluation; Drug Hypersensitivity; Humans; Hyperglycemia; Infant; Leukemia; Prednisone; Vincristine

1976
Successful remission induction in children with acute lymphocytic leukemia at high risk for treatment failure.
    Cancer, 1971, Volume: 27, Issue:6

    Topics: Amylases; Asparaginase; Blood Coagulation Disorders; Child; Child, Preschool; Daunorubicin; Female; Humans; Hyperglycemia; Infant; Leukemia, Lymphoid; Male; Prednisone; Racial Groups; Remission, Spontaneous; Uremia; Uric Acid; Vincristine

1971
Treatment of adult leukemia with L-asparaginase (NSC-109229).
    Cancer chemotherapy reports, 1971, Volume: 55, Issue:3

    Topics: Adolescent; Adult; Aged; Allopurinol; Anaphylaxis; Asparaginase; Blood Coagulation Disorders; Cytarabine; Daunorubicin; Drug Hypersensitivity; Female; Fever; Gastrointestinal Hemorrhage; Hallucinations; Humans; Hyperglycemia; Injections, Intravenous; Jaundice; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Liver; Male; Mercaptopurine; Methotrexate; Middle Aged; Oral Hemorrhage; Prednisone; Thioguanine; Uremia; Vincristine; Vomiting

1971